Known targets — ChEMBL curated mechanism
ABL1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB2AGTR1BCL2BCL2A1BCL2L1BCL2L10BCL2L2BCRBRAFCHRM1CHRNA10CHRNA9DRD1DRD2DRD3DRD4DRD5EGFRF2FLT1FLT4GCKGHSRGNRHRGRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BHTR1AHTR1BHTR1DHTR2AHTR2CHTR3AIDH2KDRKITMAOBMCL1MTTPPP4HBPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PIKFYVEROCK1ROCK2SLC18A2SLC6A2SLC6A3SLC6A4TACR1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8gyrAgyrBparCparEpol
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR known ✓ | P35968 | 1/20 | 0.36 |
| ▸ | DRD2 known ✓ | P14416 | 3/20 | 0.34 |
| ▸ | DRD3 known ✓ | P35462 | 3/20 | 0.34 |
| ▸ | IKBKB | O14920 | 2/20 | 0.44 |
| ▸ | RAF1 | P04049 | 1/20 | 0.36 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | AKT1 | P31749 | 1/20 | 0.36 |
| ▸ | AKT2 | P31751 | 1/20 | 0.36 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.36 |
| ▸ | MAP2K1 | Q02750 | 1/20 | 0.36 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | DYRK2 | Q92630 | 1/20 | 0.36 |
| ▸ | NEK1 | Q96PY6 | 1/20 | 0.36 |
| ▸ | PRKAB1 | Q9Y478 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | CD44 | P16070 | 1/20 | 0.34 |
| ▸ | NOTUM | Q6P988 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29972587 | 0.86 | CD44 (0.42) | IKBKBRAF1RPS6KB1MAPK1AKT1 | |
| SCHEMBL330078 | 0.86 | CD44 (0.42) | IKBKBRAF1RPS6KB1MAPK1AKT1 | |
| Hydrochloric Acid SCHEMBL621622 | 0.84 | CD44 (0.41) | IKBKBRAF1RPS6KB1MAPK1AKT1 | |
| Hydrochloric Acid SCHEMBL30453968 | 0.84 | CD44 (0.41) | IKBKBRAF1RPS6KB1MAPK1AKT1 | |
| SCHEMBL31518344 | 0.78 | MAOB (0.46) | CD44 | |
| SCHEMBL27793892 | 0.78 | MAOB (0.46) | CD44 | |
| Hydrochloric Acid SCHEMBL6765523 | 0.72 | KDM4E (0.45) | HTT | |
| Sulfuric Acid SCHEMBL31518346 | 0.69 | PNMT (0.50) | CD44 | |
| SCHEMBL327075 | 0.69 | CD44 (0.61) | CD44DRD2DRD3 | |
| SCHEMBL29587158 | 0.69 | CD44 (0.61) | CD44DRD2DRD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101874019-B | Process for preparing isoindole derivatives and process for preparing intermediates thereof | HOFFMANN LA ROCHE | 2013-06-12 | — | — | CN | disclosed |
| US-20130060038-A1 | PREPARATION OF DIHYDROPYRROL DERIVATIVES AS INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 2013-03-07 | — | — | US | disclosed |
| US-20120041205-A1 | PREPARATION OF DIHYDROPYRROL DERIVATIVES AS INTERMEDIATES | PFLEGER CHRISTOPHE (FR) | 2012-02-16 | — | — | US | disclosed |
| EP-2225202-B1 | Preparation of dihydropyrrol derivatives as intermediates | HOFFMANN LA ROCHE (CH) | 2011-12-28 | — | — | EP | disclosed |
| CN-101874019-A | Process for preparing isoindole derivatives and process for preparing intermediates thereof | HOFFMANN LA ROCHE | 2010-10-27 | — | — | CN | disclosed |
| EP-2225202-A2 | PROCESS FOR THE PREPARATION OF ISOINDOLE DERIVATIVES AS WELL AS A PROCESS FOR THE PREPARATION OF THEIR INTERMEDIATES | F. Hoffmann-La Roche AG (CH) | 2010-09-08 | — | — | EP | disclosed |
| WO-2009068463-A2 | PROCESS FOR THE PREPARATION OF ISOINDOLE DERIVATIVES AS WELL AS A PROCESS FOR THE PREPARATION OF THEIR INTERMEDIATES | F. HOFFMANN-LA ROCHE AG (CH) | 2009-06-04 | — | — | WO | disclosed |
| US-20090143589-A1 | Preparation of dihydropyrrol derivatives as intermediates | ROCHE PALO ALTO LLC | 2009-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090143589-A1 | Preparation of dihydropyrrol derivatives as intermediates | DHPS, QDPR, SDHA | KDR 2102/4885DRD2 102/4885DRD3 168/4885 |
| US-20120041205-A1 | PREPARATION OF DIHYDROPYRROL DERIVATIVES AS INTERMEDIATES | DHPS, QDPR, SDHA | KDR 2102/4885DRD2 102/4885DRD3 168/4885 |
| US-20130060038-A1 | PREPARATION OF DIHYDROPYRROL DERIVATIVES AS INTERMEDIATES | DHPS, QDPR, SDHA | KDR 2102/4885DRD2 102/4885DRD3 168/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.